Synergistic effects of quorum-sensing molecules and antimicrobials against Candida albicans and Pseudomonas aeruginosa biofilms: in vitro and in vivo studies

J Antimicrob Chemother. 2024 Nov 4;79(11):2828-2836. doi: 10.1093/jac/dkae293.

Abstract

Background: Candida albicans can form polymicrobial biofilms with other microorganisms, such as Pseudomonas aeruginosa, at infection sites.

Objectives: As biofilms are highly resistant to antibiotics there is a need for new antibiofilm agents that have unique targets and modes of action.

Methods: In this study the antibiofilm effects of two quorum-sensing molecules (QSMs), farnesol and tyrosol, were investigated alone and in combination with antibiotics (aztreonam, colistin, tobramycin) and antifungals (fluconazole, amphotericin B, caspofungin), against single- and dual-species biofilms of C. albicans and P. aeruginosa in in vitro and in vivo systems.

Results: It was observed that QSMs alone, especially farnesol, showed at least a 1-log reduction against preformed single- and dual-species biofilms of C. albicans and P. aeruginosa. Combination of QSMs with colistin or fluconazole was found to be effective against both single- and dual-species biofilms in vitro. Increased survival was observed in C. elegans when treated with colistin or fluconazole in combination with QSMs, compared with no treatment. Additionally, the QSMs and colistin and farnesol combinations effectively inhibited biofilm formation by C. albicans and P. aeruginosa on bronchial epithelial cells, and reduced IL-1β expression in lung bronchial epithelial cells.

Conclusions: There is a need for effective treatments for bacterial-fungal biofilm infections and, to our knowledge, there have been no studies of QSMs and antimicrobial combinations against dual-species biofilms involving C. albicans and P. aeruginosa. Hence these findings will make a significant contribution to the literature.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Antifungal Agents / pharmacology
  • Biofilms* / drug effects
  • Caenorhabditis elegans* / drug effects
  • Caenorhabditis elegans* / microbiology
  • Candida albicans* / drug effects
  • Candida albicans* / physiology
  • Drug Synergism*
  • Farnesol* / pharmacology
  • Humans
  • Mice
  • Microbial Sensitivity Tests
  • Microbial Viability / drug effects
  • Phenylethyl Alcohol / analogs & derivatives
  • Phenylethyl Alcohol / pharmacology
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa* / drug effects
  • Pseudomonas aeruginosa* / physiology
  • Quorum Sensing* / drug effects

Substances

  • Farnesol
  • Phenylethyl Alcohol
  • 4-hydroxyphenylethanol
  • Anti-Bacterial Agents
  • Antifungal Agents